ZA200504621B - Complezes of E-2-methoxy-N-(3-ä4-Ä4-methyl-4-(6-methyl-pyridin-3-yloxy-)phenylaminoÜ-quinazolin-6-ylü-allyl)-acetamide, their method of production, and use - Google Patents

Complezes of E-2-methoxy-N-(3-ä4-Ä4-methyl-4-(6-methyl-pyridin-3-yloxy-)phenylaminoÜ-quinazolin-6-ylü-allyl)-acetamide, their method of production, and use

Info

Publication number
ZA200504621B
ZA200504621B ZA200504621A ZA200504621A ZA200504621B ZA 200504621 B ZA200504621 B ZA 200504621B ZA 200504621 A ZA200504621 A ZA 200504621A ZA 200504621 A ZA200504621 A ZA 200504621A ZA 200504621 B ZA200504621 B ZA 200504621B
Authority
ZA
South Africa
Prior art keywords
methyl
ylü
phenylaminoü
complezes
quinazolin
Prior art date
Application number
ZA200504621A
Other languages
English (en)
Inventor
Zheng J Li
Andrew V Trask
Daniel T Richter
Joel Morris
Jason A Leonard
John C Kath
Carl B Thompson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA200504621B publication Critical patent/ZA200504621B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200504621A 2002-12-19 2006-01-16 Complezes of E-2-methoxy-N-(3-ä4-Ä4-methyl-4-(6-methyl-pyridin-3-yloxy-)phenylaminoÜ-quinazolin-6-ylü-allyl)-acetamide, their method of production, and use ZA200504621B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US43470002P 2002-12-19 2002-12-19

Publications (1)

Publication Number Publication Date
ZA200504621B true ZA200504621B (en) 2006-03-29

Family

ID=32682089

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200504621A ZA200504621B (en) 2002-12-19 2006-01-16 Complezes of E-2-methoxy-N-(3-ä4-Ä4-methyl-4-(6-methyl-pyridin-3-yloxy-)phenylaminoÜ-quinazolin-6-ylü-allyl)-acetamide, their method of production, and use

Country Status (21)

Country Link
US (1) US20050075354A1 (pt)
EP (1) EP1575936A1 (pt)
JP (1) JP2006512355A (pt)
KR (1) KR20050085835A (pt)
CN (1) CN1726208A (pt)
AR (1) AR042508A1 (pt)
AU (1) AU2003283743A1 (pt)
BR (1) BR0317259A (pt)
CA (1) CA2509140A1 (pt)
GT (1) GT200300287A (pt)
MX (1) MXPA05006582A (pt)
NL (1) NL1025072C2 (pt)
NO (1) NO20052803L (pt)
PA (1) PA8592501A1 (pt)
PE (1) PE20040915A1 (pt)
PL (1) PL377533A1 (pt)
RU (1) RU2005122659A (pt)
TW (1) TW200424191A (pt)
UY (1) UY28129A1 (pt)
WO (1) WO2004056802A1 (pt)
ZA (1) ZA200504621B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050192298A1 (en) * 2004-02-27 2005-09-01 Pfizer Inc Crystal forms of E-2-Methoxy-N-(3-{4-[3-methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide
JP2008542356A (ja) * 2005-06-03 2008-11-27 ファイザー・プロダクツ・インク 異常な細胞増殖の治療用の二環式誘導体
RS59494B1 (sr) 2010-02-12 2019-12-31 Pfizer Soli i polimorfi 8-fluoro-2-{4-[(metilamino)metil]fenil}-1,3,4,5-tetrahidro-6h-azepino[5,4, 3-cd]indol-6-ona
US9526648B2 (en) 2010-06-13 2016-12-27 Synerz Medical, Inc. Intragastric device for treating obesity
US10420665B2 (en) 2010-06-13 2019-09-24 W. L. Gore & Associates, Inc. Intragastric device for treating obesity
US8628554B2 (en) 2010-06-13 2014-01-14 Virender K. Sharma Intragastric device for treating obesity
US10010439B2 (en) 2010-06-13 2018-07-03 Synerz Medical, Inc. Intragastric device for treating obesity
US10779980B2 (en) 2016-04-27 2020-09-22 Synerz Medical, Inc. Intragastric device for treating obesity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6884418B1 (en) * 1989-08-04 2005-04-26 Berlex Laboratories, Inc. Use of ligand-mimicking agents and anti-neoplastic drugs in cancer therapy
GEP20063831B (en) * 2000-06-22 2006-05-25 Pfizer Prod Inc Substituted bicyclic derivatives for treatment of abnormal cell growth
ATE377009T1 (de) * 2001-11-30 2007-11-15 Osi Pharm Inc Verfahren für die herstellung substituierter bicyclischer derivate zur behandlung von anomalem zellwachstum
HUP0402662A2 (hu) * 2001-12-12 2005-05-30 Pfizer Products Inc. Az E-2-metoxi-N-(3-{4-[3-metil-4-(6-metilpiridin-3-iloxi)fenilamino]kinazolin-6-il}-allil)acetamid sói, előállításuk és rák elleni alkalmazásuk
AP2004003058A0 (en) * 2001-12-12 2004-06-30 Pfizer Prod Inc Quinazoline derivatives for the treatment of abnormal cell growth.

Also Published As

Publication number Publication date
CN1726208A (zh) 2006-01-25
WO2004056802A1 (en) 2004-07-08
NO20052803L (no) 2005-09-16
EP1575936A1 (en) 2005-09-21
GT200300287A (es) 2004-11-30
NL1025072A1 (nl) 2004-06-22
UY28129A1 (es) 2004-07-30
PE20040915A1 (es) 2005-01-18
MXPA05006582A (es) 2005-08-16
TW200424191A (en) 2004-11-16
BR0317259A (pt) 2005-11-08
NO20052803D0 (no) 2005-06-09
PL377533A1 (pl) 2006-02-06
RU2005122659A (ru) 2006-01-20
JP2006512355A (ja) 2006-04-13
AU2003283743A1 (en) 2004-07-14
CA2509140A1 (en) 2004-07-08
PA8592501A1 (es) 2004-09-16
NL1025072C2 (nl) 2007-07-24
KR20050085835A (ko) 2005-08-29
US20050075354A1 (en) 2005-04-07
AR042508A1 (es) 2005-06-22

Similar Documents

Publication Publication Date Title
IL164703A0 (en) ImidazoÄ1,2-AÜpyrazin-8-ylamines method of making and method of use thereof
EP1398930A4 (en) HIGH FREQUENCY SIGNAL RECEIVING APPARATUS AND METHOD OF MANUFACTURING THE SAME
HK1081146A1 (en) Method of producing core component, and product thereof
EP1578719A4 (en) P-HYDROXY-MILNACIPRAN STEREOISOMERS AND METHODS OF USING THE SAME
AU2003272195A8 (en) Quartz-based nanoresonators and method of fabricating same
PL375691A1 (en) Imidazolopyridines and methods of making and using the same
IL162804A0 (en) Method and device of the production of brushes
ZA200504621B (en) Complezes of E-2-methoxy-N-(3-ä4-Ä4-methyl-4-(6-methyl-pyridin-3-yloxy-)phenylaminoÜ-quinazolin-6-ylü-allyl)-acetamide, their method of production, and use
AU2003295410A8 (en) Piston and method of manufacture
EP1476150A4 (en) CARBOXY FULLERES AND USE METHOD THEREFOR
PL373884A1 (en) Flat lamp, production method thereof and application of same
IL165819A0 (en) Method of producing organic material and use of the same
GB0308934D0 (en) Labels and method of manufacture thereof
GB2385723B (en) Fuse and fuse production method
AU2003261327A8 (en) Base assemblies, methods of production and uses thereof
EP1491091A4 (en) MEANS OF PROTECTION AGAINST INSECTS AND METHODS OF PROTECTION AGAINST INSECTS
EP1568655A4 (en) MICROMACHINE AND PROCESS FOR PRODUCING THE SAME
AU2003276398A8 (en) Shearwall structure and method of making the same
PL362732A1 (en) Latex and method of its manufacture
IL173447A0 (en) Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same
EP1517879A4 (en) AMINOALKYLPHENOLS AND METHODS OF USE AND MANUFACTURE
AU2003286392A8 (en) 1microarrays and production thereof
AU2003300607A8 (en) Mannuronan c5-epimerases of brown algae, methods of obtaining same and use thereof
GB2401531B (en) Headgear and method of construction
GB0203004D0 (en) Method of manufacture and product of method